Found: 6
Select item for more details and to access through your institution.
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Effect of bcr-abl oligodeoxynucleotides on the clonogenic growth of chronic myelogenous leukaemia cells.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Treatment of Philadelphia leukemia severe combined immunodeficient mice by combination of...
- Published in:
- JNCI: Journal of the National Cancer Institute, 1997, v. 89, n. 2, p. 124, doi. 10.1093/jnci/89.2.124
- By:
- Publication type:
- Article
Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
- Published in:
- Oncogene, 2000, v. 19, n. 36, p. 4117, doi. 10.1038/sj.onc.1203754
- By:
- Publication type:
- Article
AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 12, p. 2416, doi. 10.1038/leu.2014.249
- By:
- Publication type:
- Article
Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 11, p. 2253, doi. 10.1038/leu.2013.123
- By:
- Publication type:
- Article